$2.81
-0.04-1.40%
At close: -
$2.78
-0.03-1.07%
After Hours: 6:56 PM EDT
Comments
Loading...
Scinai Immunotherapeutics (NASDAQ:SCNI) Stock, Earnings Estimates, EPS, And Revenue
Scinai Immunotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 15
EPS
$-4.000
Quarterly Revenue
$284K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$284K
Analyze the earnings history of Scinai Immunotherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Scinai Immunotherapeutics (SCNI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2023 | 2023-08-11 | $-1.20 | $-0.91 | -31.9 % |
| Mar 2023 | 2023-05-15 | $-1.20 | $-0.73 | -64.4 % |
| Mar 2023 | 2023-04-17 | $0 | $-0.10 | 100.0 % |
| Sep 2022 | 2022-11-30 | $0.06 | $-0.10 | 160.0 % |
Scinai Immunotherapeutics (SCNI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Scinai Immunotherapeutics (NASDAQ:SCNI) reporting earnings?
Scinai Immunotherapeutics (SCNI) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on August 15, 2024 for Q2.
What were the latest earnings per share (EPS) for Scinai Immunotherapeutics (NASDAQ:SCNI)?
The Actual EPS was $-4.00, which missed the estimate of $0.00.
What were Scinai Immunotherapeutics’s (NASDAQ:SCNI) revenues?
The Actual Revenue was $284K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.